Abstract
Antimicrobial peptides have recently garnered significant attention as an emerging source of potential antibiotics, due to the swift emergence of multidrug-resistant bacteria and a dwindling antibiotic pipeline. The vast majority of antimicrobial peptides are long, comprised of more than 10 amino acids, resulting in significant production costs for their synthesis while simultaneously displaying metabolic instability and relatively poor pharmacological profiles. To counter these problems, efforts have been shifted to shorter molecules and the development of new peptidomimetic approaches. In this paper, we review promising short, naturally-isolated or synthetic, antimicrobial peptides, along with their mimics, and discuss their merits as potential antibacterial agents.
Keywords: Antibacterial peptidomimetics, Antibiotics, Antimicrobial peptides, Bacterial resistance, Cationic amphiphiles, Host-defense peptides
Graphical Abstract
Current Topics in Medicinal Chemistry
Title:Short Antimicrobial Peptides and Peptide Scaffolds as Promising Antibacterial Agents
Volume: 16 Issue: 11
Author(s): Ronald Domalaon, George G. Zhanel and Frank Schweizer
Affiliation:
Keywords: Antibacterial peptidomimetics, Antibiotics, Antimicrobial peptides, Bacterial resistance, Cationic amphiphiles, Host-defense peptides
Abstract: Antimicrobial peptides have recently garnered significant attention as an emerging source of potential antibiotics, due to the swift emergence of multidrug-resistant bacteria and a dwindling antibiotic pipeline. The vast majority of antimicrobial peptides are long, comprised of more than 10 amino acids, resulting in significant production costs for their synthesis while simultaneously displaying metabolic instability and relatively poor pharmacological profiles. To counter these problems, efforts have been shifted to shorter molecules and the development of new peptidomimetic approaches. In this paper, we review promising short, naturally-isolated or synthetic, antimicrobial peptides, along with their mimics, and discuss their merits as potential antibacterial agents.
Export Options
About this article
Cite this article as:
Domalaon Ronald, Zhanel G. George and Schweizer Frank, Short Antimicrobial Peptides and Peptide Scaffolds as Promising Antibacterial Agents, Current Topics in Medicinal Chemistry 2016; 16 (11) . https://dx.doi.org/10.2174/1568026615666150915112459
DOI https://dx.doi.org/10.2174/1568026615666150915112459 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Prevention and Treatment of Regimen-Related Mucosal Toxicity
Recent Patents on Anti-Cancer Drug Discovery Prognostic Parameters in Myeloid Malignancies in a Historical Context – From Microscopy to Individualized Medicine
Current Drug Targets The Rapidly Changing Composition of the Global Street Drug Supply and its Effects on High-risk Groups for COVID-19
Current Psychopharmacology Recent Progress in Histone Deacetylase Inhibitors as Anticancer Agents
Current Medicinal Chemistry Immunomodulatory Drugs as a Therapy for Multiple Myeloma
Current Pharmaceutical Biotechnology Unleashing the Guardian: The Targetable BCR-ABL/HAUSP/PML/PTEN Network in Chronic Myeloid Leukemia
Current Drug Targets Targeting Rho GTPases by Peptidic Structures
Current Pharmaceutical Design Macrocyclic Proteasome Inhibitors
Current Medicinal Chemistry Lymphoproliferative Lesions in IgG4-Related Disease
Current Immunology Reviews (Discontinued) Regulation of EMT by Notch Signaling Pathway in Tumor Progression
Current Cancer Drug Targets VEGF Inhibitors and Prostate Cancer Therapy
Current Molecular Pharmacology Gastric Cancer: Nanoparticles as Tools to Improve Treatment Efficacy
Current Pharmaceutical Design Patent Selections:
Recent Patents on Anti-Infective Drug Discovery ras Genes and Human Cancer: Different Implications and Different Roles
Current Genomics Antiviral Treatment of Cytomegalovirus Infection
Infectious Disorders - Drug Targets Delivery of Nanoparticles for Treatment of Brain Tumor
Current Drug Metabolism Novel Molecular-Targeted Therapeutics for the Treatment of Cancer
Anti-Cancer Agents in Medicinal Chemistry Receptor-Specific Peptides for Targeting of Liposomal, Polymeric, and Dendrimeric Nanoparticles in Cancer Diagnosis and Therapy
Current Molecular Imaging (Discontinued) Secondary Neoplasms in Children Treated for Cancer
Current Pediatric Reviews Zevalin™: 90Yttrium Labeled Anti-CD20 (Ibritumomab Tiuxetan), a New Treatment for Non-Hodgkin ’ s Lymphoma
Current Pharmaceutical Biotechnology